[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-338795-105":59,"doc-detail-338795-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","cyclin-b2-impairs-the-p53-signaling-in-nasopharyngeal-carcinoma-research-open-access-abstract","Cyclin B2 impairs the p53 signaling in nasopharyngeal carcinoma - Research Open Access - Abstract","","Background Cyclin B2 (CCNB2) functions as an oncogene in several cancers, including nasopharyngeal carcinoma (NPC), yet the epigenetic mechanism driving CCNB2 overexpression in NPC remains unclear. This study characterizes how CCNB2 regulates NPC phenotypes and identifies the molecular pathway involved. Methods use GEO-derived differential methylation and expression analyses, functional enrichment, PPI hub identification, and experimental validation. Results show CCNB2 hypomethylation correlates with overexpression, and CCNB2 silencing suppresses migration, proliferation, cell-cycle entry, and EMT. Upstream regulation implicates JMJD6-mediated demethylation that increases NPC activity, while p53 pathway inhibition modulates these effects.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/cyclin-b2-impairs-the-p53-signaling-in-nasopharyngeal-carcinoma-research-open-access-abstract/338795/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/cyclin-b2-impairs-the-p53-signaling-in-nasopharyngeal-carcinoma-research-open-access-abstract/338795.png","ImageObject",300,407,{"name":92,"@type":93},"Jiven","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-07","2026-09-21",true,{"@type":102,"interactionType":103,"userInteractionCount":34},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What is the main question of the study?","Question",{"text":112,"@type":113},"How CCNB2 is overexpressed in nasopharyngeal carcinoma through epigenetic regulation and how this affects the p53 signaling pathway.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"What role does CCNB2 play in NPC based on the results?",{"text":117,"@type":113},"CCNB2 is hypomethylated and overexpressed in NPC, and silencing CCNB2 inhibits migration, proliferation, cell-cycle entry, and EMT.",{"name":119,"@type":110,"acceptedAnswer":120},"How is CCNB2 upregulation linked to JMJD6 and p53?",{"text":121,"@type":113},"JMJD6 is overexpressed and upregulates CCNB2 by demethylation; CCNB2 then blocks the p53 pathway, and a p53 pathway inhibitor reverses CCNB2-silencing effects.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},338795,1790194077,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":34,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099513958607,"https://ap-avatar.wpscdn.com/avatar/100002390cf8733938c?x-image-process=image/resize,m_fixed,w_180,h_180&k=1778829742770036399","Liu et al. BMC Cancer (2024) 24:25 BMC Cancer  \n[https://doi.org/10.1186/s12885-023-11768-4](https://doi.org/10.1186/s12885-023-11768-4)  \nRESEARCH Open Access  \nCyclin B2 impairs the p53 signaling in nasopharyngeal carcinoma  \nQinsong Liu1, Yong Yuan1, Xiaofen Shang1 and Lu Xin1*  \nAbstract  \nBackground Cyclin B2 (CCNB2), a member of the cyclin family, is an oncogene in multiple cancers, including nasopharyngeal carcinoma (NPC) . However, the epigenetics mechanism for CCNB2 overexpression in NPC remains unclear. This study dissects the regulatory role of CCNB2 in NPC and the molecular mechanism.  \nMethods Differentially methylated genes (DMG) and differentially expressed genes (DEG) were screened out in GSE52068 and GSE13597 databases, respectively, and candidate targets were identified by theVenn diagram. GO annotation and pathway enrichment analyses were performed on selected DMG and DEG, and a PPI network was constructed to pinpoint hub genes. PCR and qMSP were conducted to detect the expression and methylation of CCNB2 in cells. The siRNA targeting CCNB2 was transfected into NPC cells, and the migration, proliferation, cell cycle, epithelial-mesenchymal transition (EMT), tumorigenesis, and metastasis were examined. The upstream factor responsible for CCNB2 overexpression in NPC was explored. The p53 activity in NPC cells was assessed using western blot analysis.  \nResults CCNB2 showed hypomethylation and overexpression in NPC. CCNB2 silencing inhibited cell migration, proliferation, cell cycle entry, and EMT. JMJD6 was overexpressed in NPC and upregulated CCNB2 through demethylation. JMJD6 reversed the effects of CCNB2 downregulation, resulting in elevated cellular activity in vitro and tumorigenic and metastatic activities in vivo. CCNB2 blocked the p53 pathway, while the p53 pathway inhibitor reversed the effect of CCNB2 silencing to increase the activity of NPC cells.  \nConclusions JMJD6 enhanced CCNB2 transcription by demethylating CCNB2, thereby repressing the p53 pathway and promoting NPC progression.  \nKeywords JMJD6, CCNB2, p53 pathway, Methylation, Nasopharyngeal carcinoma  \n*Correspondence: Lu Xin [xinlu357076@126.com](xinlu357076@126.com)  \n1Department of Otolaryngology, Qingdao Municipal Hospital, NO. 1,  \nShibei District, Jiaozhou Road, 266011  \nQingdao, Shandong, P. R. China  \n© The Author(s) 2024. Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creativecommons.org/licenses/by/4.0/](http://creativecommons.org/licenses/by/4.0/. The)[. The](http://creativecommons.org/licenses/by/4.0/. The)[ ](http://creativecommons.org/licenses/by/4.0/. The)Creative Commons Public Domain Dedication waiver ([http://creativecommons.org/publicdomain/zero/1.0/](http://creativecommons.org/publicdomain/zero/1.0/)) applies to the data made available in this article, unless otherwise stated in a credit line to the data.  \nLiu et al. BMC Cancer (2024) 24:25  \nBackground  \nNasopharyngeal carcinoma (NPC) of the undifferentiated subtype is still endemic in southern China, with a peak incidence reaching 30 per 100,000 persons each year [1]. Radiotherapy remains the main treatment modality, and radiation therapy combined with chemotherapy is recommended for patients with locoregionally adv","cbCainZuyluEqG63","https://ap.wps.com/l/cbCainZuyluEqG63","pdf",12583363,14,"English","# Abstract\n## Background\n## Methods\n## Results\n## Conclusions\n# Background\n## Treatment and clinical context for NPC\n## EMT and epigenetic regulation\n# Rationale for CCNB2 and JMJD6","[{\"question\":\"What is the main question of the study?\",\"answer\":\"How CCNB2 is overexpressed in nasopharyngeal carcinoma through epigenetic regulation and how this affects the p53 signaling pathway.\"},{\"question\":\"What role does CCNB2 play in NPC based on the results?\",\"answer\":\"CCNB2 is hypomethylated and overexpressed in NPC, and silencing CCNB2 inhibits migration, proliferation, cell-cycle entry, and EMT.\"},{\"question\":\"How is CCNB2 upregulation linked to JMJD6 and p53?\",\"answer\":\"JMJD6 is overexpressed and upregulates CCNB2 by demethylation; CCNB2 then blocks the p53 pathway, and a p53 pathway inhibitor reverses CCNB2-silencing effects.\"}]","Cyclin B2 impairs the p53 signaling in nasopharyngeal carcinoma - Research Open Access - Abstract | PDF",1790025742,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/d56d47de2f194720b6f4c8539a82aa0d.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/cf8573e1282d8812dc7fb5fd1fcc4dcb.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/fccd2d8b7a3caf8afe8ef90ed3bdb6d3.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/1a4369e7f339187ebf1c2b136d83eacb.webp",980,1306]